HFCAS OpenIR

Browse/Search Results:  1-2 of 2 Help

Selected(0)Clear Items/Page:    Sort:
Inhibition of the deubiquitinating enzyme USP47 as a novel targeted therapy for hematologic malignancies expressing mutant EZH2 期刊论文
LEUKEMIA, 2022
Authors:  Yang, Jing;  Weisberg, Ellen L.;  Qi, Shuang;  Ni, Wei;  Mei, Husheng;  Wang, Zuowei;  Meng, Chengcheng;  Zhang, Shengzhe;  Hou, Mingqi;  Qi, Ziping;  Wang, Aoli;  Jiang, Yunyun;  Jiang, Zongru;  Huang, Tao;  Liu, Qingwang;  Magin, Robert S.;  Doherty, Laura;  Wang, Wenchao;  Liu, Jing;  Buhrlage, Sara J.;  Liu, Qingsong;  Griffin, James D.
Favorite  |  View/Download:25/0  |  Submit date:2022/02/14
Multicenter clinical study for evaluation of efficacy and safety of transdermal fentanyl matrix patch in treatment of moderate to severe cancer pain in 474 Chinese cancer patients 期刊论文
CHINESE JOURNAL OF CANCER RESEARCH, 2011, 卷号: 23
Authors:  Zhu Yulin;  Song Guohong;  Liu Duanqi;  Zhang Xi;  Liu Kuifeng;  Zang Aihua;  Cheng Ying;  Cao Guochun;  Liang Jun;  Ma Xuezhen;  Ding Xin;  Wang Bin;  Li Weilian;  Hu Zuowei;  Feng Gang;  Huang Jiangjin;  Zheng Xiao;  Jiao Shunchang;  Wu Rong;  Ren Jun
Favorite  |  View/Download:7/0  |  Submit date:2020/12/28
AVAILABLE RESERVOIR FORMULATION  LONG-TERM TREATMENT  QUALITY-OF-LIFE  PHARMACOLOGICAL-PROPERTIES  THERAPEUTIC-EFFICACY  DELIVERY-SYSTEM  ORAL MORPHINE  OPIOIDS  TRIAL  PHARMACOKINETICS  Transdermal fentanyl matrix patch (TDF)  Cancer pain  Efficacy  Safety  Quality of life